During the past decade, Glenn Biggs Institute for Alzheimer's & Neurodegenerative Diseases conducted 3 clinical trials. In the 10-year time frame, 3 clinical trials started and 1 clinical trials were completed, i.e. on average, 33.3% percent of trials that started reached the finish line to date. In the past 5 years, 3 clinical trials started and 1 clinical trials were completed. i.e. 33.3% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Glenn Biggs Institute for Alzheimer's & Neurodegenerative Diseases" #1 collaborator was "Mayo Clinic" with 1 trials as a collaborator and "Owens Medical Research Foundation" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 2 trials.

According to Clinical.Site data, the most researched conditions in "Glenn Biggs Institute for Alzheimer's & Neurodegenerative Diseases" are "Alzheimer Disease" (2 trials), "Alzheimer Disease, Early Onset" (1 trials) and "Mild Cognitive Impairment" (1 trials). Many other conditions were trialed in "Glenn Biggs Institute for Alzheimer's & Neurodegenerative Diseases" in a lesser frequency.

Most popular intervention types in "Glenn Biggs Institute for Alzheimer's & Neurodegenerative Diseases" are "Drug" (3 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "3TC" (1 trials), "Dasatinib + Quercetin" (1 trials), "Placebo" (1 trials) and "Rapamycin" (1 trials). Other intervention names were less common.

The vast majority of trials in "Glenn Biggs Institute for Alzheimer's & Neurodegenerative Diseases" are 3 trials for "All" genders.

Currently, there are NaN active trials in "Glenn Biggs Institute for Alzheimer's & Neurodegenerative Diseases". undefined are not yet recruiting, 1 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in Glenn Biggs Institute for Alzheimer's & Neurodegenerative Diseases, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Glenn Biggs Institute for Alzheimer's & Neurodegenerative Diseases, 2 "Phase 1" clinical trials were conducted, 3 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".